Short-term Effect of Tamsulosin and Finasteride Monotherapy and their Combination on Nigerian Men with Benign Prostatic Hyperplasia.

Autor:	Odusanya BO; Department of Surgery, General Hospital, Marina, Lagos, Nigeria., Tijani KH; Department of Surgery, College of Medicine, University of Lagos, Lagos, Nigeria., Jeje EA; Department of Surgery, College of Medicine, University of Lagos, Lagos, Nigeria., Ogunjimi MA; Department of Surgery, College of Medicine, University of Lagos, Lagos, Nigeria., Ojewola RW; Department of Surgery, College of Medicine, University of Lagos, Lagos, Nigeria.
Jazyk:	angličtina
Zdroj:	Nigerian journal of surgery : official publication of the Nigerian Surgical Research Society [Niger J Surg] 2017 Jan-Jun; Vol. 23 (1), pp. 5-10.
DOI:	10.4103/1117-6806.199963
Abstrakt:	Objective: The objective of this study was to assess the efficacy of tamsulosin and finasteride monotherapies, and their combination in men with benign prostatic hyperplasia (BPH). Materials and Methods: This is a prospective single-blind randomized study of ninety men with BPH who were managed using drugs. The International Prostate Symptom Score (IPSS), peak urinary flow rate, and prostate volume were measured as parameters for assessment at the beginning, 3 months, and 6 months of the study. Results: The mean age of patients was 61.65 with a range of 44-81 years. There was a progressive and sustained improvement in the IPSS score in all patient groups with mean decrease at 3 months of 7.24 (42.59%), 7.60 (41.85%), and 7.24 (40.61%) and at 6 months of 8.14 (47.88%), 10.33 (56.88%), and 11.1 (62.25%) in the tamsulosin, finasteride, and combination groups, respectively. There was an increase in peak urinary flow rate in all groups with mean increase at 3 months of 0.98, 0.05, and 3.55 (ml/s) and at 6 months of 4.11, 0.87, and 3.74 (ml/s) in the tamsulosin, finasteride, and combination groups, respectively. There was a reduction in the prostate volume in the finasteride and combination groups at 6 months of 6.8 and 6.32 cm 3 , respectively, while the tamsulosin group recorded an increase. Conclusion: At the end of 6 months, tamsulosin monotherapy and combination therapy appear to be equally effective in the treatment of lower urinary tract symptoms BPH while finasteride monotherapy appears to be the least effective. Bothersome, side effects were more in patients taking finasteride alone or as combination therapy. Competing Interests: There are no conflicts of interest.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu